Mesoblast Limited (MESO) 追踪市盈率为负值 -23.3, 表示公司目前在过去十二个月 (TTM) 基础上处于亏损状态。 前瞻市盈率 157.3 基于分析师预估，预计将恢复盈利。 追踪盈利收益率为 -4.29%, 前瞻盈利收益率 0.64%. PEG 0.69 (Peter Lynch 低估标准 ≤1.0).
本页证实的标准:
SharesGrow 综合评分： 39/100 其中 1/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -103.2 | 1.07 | 0.81 | 10.01 | - |
| 2017 | -11.1 | -0.01 | 1.65 | 354.43 | - |
| 2018 | -14.5 | 0.32 | 0.94 | 29.53 | - |
| 2019 | -5.6 | -0.04 | 1.04 | 29.86 | - |
| 2020 | -15.5 | 0.93 | 2.19 | 37.46 | - |
| 2021 | -9.2 | -1.37 | 1.56 | 121.40 | - |
| 2022 | -3.3 | 0.18 | 0.61 | 29.69 | - |
| 2023 | -8.0 | 0.32 | 1.31 | 87.34 | - |
| 2024 | -7.6 | 0.86 | 1.39 | 113.35 | - |
| 2025 | -12.9 | 2.44 | 2.20 | 76.48 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-0.11 | $42.55M | $-4.13M | -9.7% |
| 2017 | $-1.90 | $2.41M | $-76.82M | -3184.7% |
| 2018 | $-0.76 | $17.34M | $-35.29M | -203.5% |
| 2019 | $-1.80 | $16.72M | $-89.8M | -537% |
| 2020 | $-1.50 | $32.16M | $-77.94M | -242.4% |
| 2021 | $-1.60 | $7.46M | $-98.81M | -1325.3% |
| 2022 | $-1.30 | $10.21M | $-91.35M | -894.6% |
| 2023 | $-0.98 | $7.5M | $-81.89M | -1091.7% |
| 2024 | $-0.89 | $5.9M | $-87.96M | -1490.3% |
| 2025 | $-0.84 | $17.2M | $-102.14M | -593.9% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $-0.30 | $-0.50 – $-0.10 | $127.6M | $111.26M – $154.3M | 2 |
| 2027 | $0.19 | $0.15 – $0.24 | $232.19M | $202.46M – $280.77M | 1 |
| 2028 | $0.90 | $0.75 – $1.14 | $471.43M | $411.07M – $570.06M | 1 |
| 2029 | $1.47 | $1.23 – $1.87 | $909.47M | $793.02M – $1.1B | 1 |
| 2030 | $3.32 | $2.77 – $4.22 | $886.44M | $772.93M – $1.07B | 1 |
